Australian innovative SMEs and start ups in the digital health space are invited to apply for the 2017 intake to the Texas Medical Centre Accelerator program

Innovative SMEs and startups in the digital health space are invited to apply for the Texas Medical Centre Accelerator (TMCx) online here by 23 December 2017.  This is a unique opportunity,  with TMC accepting up to  4 Australian firms, at no charge, to be part of their Accelerator program, commencing 13 February 2017.

The 4 month program will be offered on a competitive basis to Australian companies by the TMC.  Participating companies will be responsible for funding their own travel, accommodation and other expenses while in Houston.

  • Located in the TMC Innovation Institute, the TMCx accelerator program provides startup companies with shared workspace, a curriculum tailored to the needs of health care entrepreneurs and the guidance of over 120 advisors from the front lines of the industry. Companies have access to the world’s largest medical center, all without membership fees or equity sharing.
  • Participants further develop their companies by attending a variety of workshops and hands-on events to gain insights from experts in every facet of running a health-related business in the US: clinical trials, FDA regulations, HIPAA/HITECH compliance, hospital procurement, commercial pilots, intellectual property, licensing, fundraising, marketing and other critical areas.
  • Participants work with the TMCx team to refine strategies and build relationships across the Texas Medical Center. Companies network with key thought leaders and mentors during the Advisor Pitch Event, the TMC Expert Forum and other scheduled sessions. The four-month program culminates with TMCx Demo Day, an exclusive presentation to hundreds of investors, corporate partners, hospital stakeholders, media and other guests.

HISA (Health Informatics Society of Australia) has formed an alliance with the Texas Medical Centre to drive the BioBridge initiative in Australia.

This initiative is supported by Austrade.